CIRRHOSIS

This study aims to see if adding a protein called albumin to standard treatment helps patients with severe liver disease who are experiencing life-threatening bleeding from enlarged veins. It will involve 60 adults with cirrhosis and active bleeding. Participants will be randomly…

This study is testing whether a combination of a digital exercise and nutrition app, plus protein and creatine supplements, can help people with liver cirrhosis maintain their muscle strength and physical function. Researchers will enroll 100 adults with cirrhosis to use the app …

This study is testing a new, less invasive way to treat a dangerous bleeding complication in people with advanced liver disease (cirrhosis). Doctors will use a special ultrasound scope to inject tiny particles into the spleen, aiming to reduce pressure in the liver's blood vessel…

This study compares two common water pills (bumetanide and furosemide) for hospitalized liver cirrhosis patients with fluid buildup. Researchers want to see which medication helps patients lose more fluid weight safely and reduces hospital complications. The trial will enroll 500…

This study is testing whether artificial intelligence (AI) can find early signs of fatty liver disease by analyzing routine heart ultrasound images. It will enroll 2000 adults who have already had a heart scan. The main goal is to see if this AI tool helps doctors diagnose liver …

This study aims to see if special ultrasound scans can accurately measure pressure in the liver's blood vessels without using invasive needle procedures. Researchers will test 107 adults with liver cirrhosis who have already had or need the standard invasive pressure test. They'l…

This study aims to understand how the body's automatic nervous system is involved in liver cancer (HCC). Researchers will measure heart rate, skin responses, and psychological traits in 100 people with liver cirrhosis, some with and some without early cancer. The goal is to find …

This study aims to understand how well current treatments work for people with liver cirrhosis who develop a life-threatening bloodstream infection called sepsis. Researchers will look back at the medical records of 1,600 patients to see which treatment approaches were linked to …

This study aims to understand if tiny plastic particles, called microplastics and nanoplastics, build up in the livers of people with cirrhosis (scarring of the liver). Researchers will compare liver tissue from 30 people with cirrhosis to tissue from people without liver disease…

This study aims to understand how changes in gut bacteria and lactate levels might relate to the worsening of liver cirrhosis. Researchers will observe 200 people, including healthy individuals and those with cirrhosis, to look for patterns. The goal is to gather knowledge about …